After-Hours Movers 09/27: (OMN) (PRGS) (JBL) (ACTS) (SNX) (TSPT) Higher;
Tweet
Share
E-mail
Get Alerts OMN Hot Sheet
Join SI Premium – FREE
Omnova Solutions, Inc. (NYSE: OMN) 22% HIGHER; reported Q3 EPS of $0.09, $0.04 better than the analyst estimate of $0.05. Revenue for the quarter came in at $331.1 million versus the consensus estimate of $310 million. Sees FY11 adj-EPS at the top end of its previously issued 40-44 cent range. The Street is currently looking for FY11 EPS of 40 cents.
Progress Software Corp (NASDAQ: PRGS) 10% HIGHER; reported Q3 EPS of $0.31, $0.02 better than the analyst estimate of $0.29. Revenue for the quarter came in at $128.3 million versus the consensus estimate of $128.05 million. Sees Q3 2011 EPS of $0.30-$0.33, versus the consensus of $0.42. Sees Q3 2011 revenue of $130-$134 million, versus the consensus of $145.37 million. Sees FY2011 EPS of $1.42-$1.45, versus the consensus of $1.51. Sees FY2011 revenue of $527-$531 million, versus the consensus of $542.4 million.
Jabil Circuit, Inc. (NYSE: JBL) 7.2% HIGHER; reported Q4 EPS of $0.52, $0.04 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $4.28 billion versus the consensus estimate of $4.19 billion. Sees Q1 core EPS of 62-70c, vs. cons. 61 cents. See sales $4.3-$4.5 billion, which compares to the Street estimate of $4.41 billion.
Actions Semiconductor Co., Ltd. (Nasdaq: ACTS) 7% HIGHER; provided an update to its third quarter financial outlook. For the third quarter of 2011, Actions expects to report revenue in the range of $15.0 million to $15.5 million and gross margin of approximately 40%. The company's previous guidance was for the third quarter revenue to be in the range of $12.0 to $13.0 million and gross margin of approximately 40%.
SYNNEX Corp. (NYSE: SNX) 5% HIGHER; reported Q3 EPS of $1.07, $0.18 better than the analyst estimate of $0.89. Revenue for the quarter came in at $2.57 billion versus the consensus estimate of $2.57 billion. Sees Q4 EPS of $1.11-$1.15, vs. the consensus of $1.11. See sales $2.78-$2.88 billion, which compares to the Street estimate of $2.82 billion.
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) 4% HIGHER; reports that the company has resubmitted the New Drug Application for Intermezzo (zolpidem tartrate sublingual tablet) to the U.S. Food and Drug Administration (FDA). The resubmission follows a meeting between Transcept and the FDA on September 14, 2011 to discuss issues raised by the FDA in the July 2011 Complete Response Letter.
Accenture (NYSE: ACN) 3.4% HIGHER; reported Q4 EPS of $0.91, $0.02 better than the analyst estimate of $0.89. Revenue for the quarter came in at $7.17 billion versus the consensus estimate of $6.51 billion. Sees Q1 2012 revenue of $6.8-$7.0 billion, versus the consensus of $6.7 billion. Sees FY12 sales up 7-10 and EPS of $3.80-$3.88. Adds $5 billion to buyback. Raises semi-annual dividend 50 percent to $0.675.
Progress Software Corp (NASDAQ: PRGS) 10% HIGHER; reported Q3 EPS of $0.31, $0.02 better than the analyst estimate of $0.29. Revenue for the quarter came in at $128.3 million versus the consensus estimate of $128.05 million. Sees Q3 2011 EPS of $0.30-$0.33, versus the consensus of $0.42. Sees Q3 2011 revenue of $130-$134 million, versus the consensus of $145.37 million. Sees FY2011 EPS of $1.42-$1.45, versus the consensus of $1.51. Sees FY2011 revenue of $527-$531 million, versus the consensus of $542.4 million.
Jabil Circuit, Inc. (NYSE: JBL) 7.2% HIGHER; reported Q4 EPS of $0.52, $0.04 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $4.28 billion versus the consensus estimate of $4.19 billion. Sees Q1 core EPS of 62-70c, vs. cons. 61 cents. See sales $4.3-$4.5 billion, which compares to the Street estimate of $4.41 billion.
Actions Semiconductor Co., Ltd. (Nasdaq: ACTS) 7% HIGHER; provided an update to its third quarter financial outlook. For the third quarter of 2011, Actions expects to report revenue in the range of $15.0 million to $15.5 million and gross margin of approximately 40%. The company's previous guidance was for the third quarter revenue to be in the range of $12.0 to $13.0 million and gross margin of approximately 40%.
SYNNEX Corp. (NYSE: SNX) 5% HIGHER; reported Q3 EPS of $1.07, $0.18 better than the analyst estimate of $0.89. Revenue for the quarter came in at $2.57 billion versus the consensus estimate of $2.57 billion. Sees Q4 EPS of $1.11-$1.15, vs. the consensus of $1.11. See sales $2.78-$2.88 billion, which compares to the Street estimate of $2.82 billion.
Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) 4% HIGHER; reports that the company has resubmitted the New Drug Application for Intermezzo (zolpidem tartrate sublingual tablet) to the U.S. Food and Drug Administration (FDA). The resubmission follows a meeting between Transcept and the FDA on September 14, 2011 to discuss issues raised by the FDA in the July 2011 Complete Response Letter.
Accenture (NYSE: ACN) 3.4% HIGHER; reported Q4 EPS of $0.91, $0.02 better than the analyst estimate of $0.89. Revenue for the quarter came in at $7.17 billion versus the consensus estimate of $6.51 billion. Sees Q1 2012 revenue of $6.8-$7.0 billion, versus the consensus of $6.7 billion. Sees FY12 sales up 7-10 and EPS of $3.80-$3.88. Adds $5 billion to buyback. Raises semi-annual dividend 50 percent to $0.675.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- Provident Financial Services (PFS) Declares $0.24 Quarterly Dividend; 7% Yield
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Dividend, After-Hours MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
